Contravisory Investment Management Inc. increased its position in C R Bard Inc (NYSE:BCR) by 349.2% during the first quarter, Holdings Channel reports. The fund owned 548 shares of the company’s stock after buying an additional 426 shares during the period. Contravisory Investment Management Inc.’s holdings in C R Bard were worth $136,000 as of its most recent SEC filing.
Several other institutional investors also recently modified their holdings of the company. SRS Capital Advisors Inc. bought a new position in shares of C R Bard during the fourth quarter worth about $133,000. Cantab Capital Partners LLP bought a new position in shares of C R Bard during the fourth quarter worth about $200,000. Soros Fund Management LLC bought a new position in shares of C R Bard during the fourth quarter worth about $202,000. Shinko Asset Management Co. Ltd. boosted its position in shares of C R Bard by 60.1% in the third quarter. Shinko Asset Management Co. Ltd. now owns 975 shares of the company’s stock worth $219,000 after buying an additional 366 shares during the last quarter. Finally, Boothbay Fund Management LLC bought a new position in shares of C R Bard during the fourth quarter worth about $231,000. Institutional investors and hedge funds own 86.89% of the company’s stock.
C R Bard Inc (NYSE:BCR) traded up 0.25% during mid-day trading on Monday, reaching $250.01. The company had a trading volume of 21,253 shares. The stock has a market cap of $18.01 billion, a PE ratio of 35.56 and a beta of 0.63. C R Bard Inc has a 12 month low of $202.34 and a 12 month high of $252.25. The firm’s 50-day moving average price is $245.10 and its 200-day moving average price is $227.58.
C R Bard (NYSE:BCR) last issued its earnings results on Thursday, January 26th. The company reported $2.77 EPS for the quarter, beating the consensus estimate of $2.74 by $0.03. The company earned $967.10 million during the quarter, compared to analysts’ expectations of $956.12 million. C R Bard had a net margin of 14.31% and a return on equity of 48.48%. During the same quarter in the previous year, the company posted $2.43 EPS. The business’s revenue for the quarter was up 10.0% compared to the same quarter last year. Equities research analysts forecast that C R Bard Inc will post $11.64 EPS for the current fiscal year.
COPYRIGHT VIOLATION NOTICE: This news story was originally reported by sleekmoney and is the sole property of of sleekmoney. If you are accessing this news story on another domain, it was stolen and republished in violation of US and international trademark & copyright law. The original version of this news story can be accessed at http://sleekmoney.com/contravisory-investment-management-inc-buys-426-shares-of-c-r-bard-inc-bcr/1733355.html.
Several brokerages have recently commented on BCR. Zacks Investment Research cut C R Bard from a “buy” rating to a “hold” rating in a research report on Wednesday, December 21st. BMO Capital Markets reaffirmed a “buy” rating on shares of C R Bard in a research report on Friday, January 27th. Morgan Stanley raised C R Bard from an “equal weight” rating to an “overweight” rating and raised their target price for the stock from $240.00 to $260.00 in a research report on Tuesday, January 3rd. Raymond James Financial, Inc. raised C R Bard from an “outperform” rating to a “strong-buy” rating and raised their target price for the stock from $250.00 to $265.00 in a research report on Thursday, January 5th. Finally, Needham & Company LLC reaffirmed a “hold” rating on shares of C R Bard in a research report on Friday, January 27th. Eight analysts have rated the stock with a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company. C R Bard currently has a consensus rating of “Buy” and an average target price of $247.85.
In other C R Bard news, insider Jim C. Beasley sold 4,390 shares of the stock in a transaction dated Tuesday, February 21st. The stock was sold at an average price of $245.00, for a total transaction of $1,075,550.00. Following the completion of the transaction, the insider now owns 26,625 shares in the company, valued at approximately $6,523,125. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, Chairman Timothy M. Ring sold 20,324 shares of the stock in a transaction dated Thursday, February 9th. The stock was sold at an average price of $239.56, for a total value of $4,868,817.44. Following the transaction, the chairman now owns 127,954 shares of the company’s stock, valued at approximately $30,652,660.24. The disclosure for this sale can be found here. In the last 90 days, insiders sold 96,769 shares of company stock valued at $23,216,321. 0.97% of the stock is owned by corporate insiders.
C R Bard Company Profile
C. R. Bard, Inc (Bard) is engaged in designing, manufacturing, packaging, distribution and sale of medical, surgical, diagnostic and patient care devices. The Company operates through the manufacture and sale of medical devices segment. It sells a range of products to hospitals, individual healthcare professionals, extended care facilities and alternate site facilities on a global basis.
Want to see what other hedge funds are holding BCR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for C R Bard Inc (NYSE:BCR).
This story was originally published by sleekmoney (http://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at http://sleekmoney.com/contravisory-investment-management-inc-buys-426-shares-of-c-r-bard-inc-bcr/1733355.html
Receive News & Ratings for C R Bard Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for C R Bard Inc and related companies with MarketBeat.com's FREE daily email newsletter.